{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T17:40:22Z","timestamp":1784914822377,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100032584","name":"Organization Department of Gansu Provincial Party Committee","doi-asserted-by":"publisher","award":["2023RCXM06"],"award-info":[{"award-number":["2023RCXM06"]}],"id":[{"id":"10.13039\/100032584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032584","name":"Organization Department of Gansu Provincial Party Committee","doi-asserted-by":"publisher","award":["2022B-025"],"award-info":[{"award-number":["2022B-025"]}],"id":[{"id":"10.13039\/100032584","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.crad.2025.107019","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T08:11:40Z","timestamp":1752567100000},"page":"107019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Combining intratumoral and peritumoral multimodality magnetic resonance imaging (MRI) to predict the expression level of human epidermal growth factor receptor-2 (HER-2) in breast cancer"],"prefix":"10.1016","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5111-5826","authenticated-orcid":false,"given":"Wen","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9197-4372","authenticated-orcid":false,"given":"Yuhui","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7632-1922","authenticated-orcid":false,"given":"Junqiang","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2025.107019_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1470-2045(13)70567-9","article-title":"Breast cancer in China","volume":"15","author":"Fan","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.crad.2025.107019_bib2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41523-024-00652-4","article-title":"The survival benefit of adjuvant trastuzumab with or without chemotherapy in the management of small (T1mic, T1a, T1b, T1c), node negative HER2+ breast cancer","volume":"10","author":"Johnson","year":"2024","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.crad.2025.107019_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3390\/ijms25115910","article-title":"Comparing the HER2 status of the primary tumor to that of disseminated tumor cells in early breast cancer","volume":"25","author":"Volmer","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.crad.2025.107019_bib4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12951-024-02600-7","article-title":"Combined SERS\u2013Raman screening of HER2-overexpressing or silenced breast cancer cell lines","volume":"22","author":"Spaziani","year":"2024","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.crad.2025.107019_bib5","article-title":"MRI-based machine learning radiomics can predict HER2 expression level and pathologic response after neoadjuvant therapy in HER2 overexpressing breast cancer","volume":"61","author":"Bitecourt","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.crad.2025.107019_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1245\/s10434-023-14439-7","article-title":"Are there more HER2 FISH in the sea? An institution's experience in identifying HER2 positivity using fluorescent in situ hybridization in patients with HER2 negative immunohistochemistry","volume":"31","author":"Suydam","year":"2024","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.crad.2025.107019_bib7","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/jmri.29447","article-title":"Preoperative differentiation of HER2-zero and HER2-low from HER2-positive invasive ductal breast cancers using BI-RADS MRI features and machine learning modeling","volume":"61","author":"Zhou","year":"2025","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.crad.2025.107019_bib8","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/jmri.27651","article-title":"Intratumoral and peritumoral radiomics based on functional parametric maps from breast DCE-MRI for prediction of HER-2 and Ki-67 status","volume":"54","author":"Li","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.crad.2025.107019_bib9","article-title":"Texture analysis using semiquantitative kinetic parameter maps from DCE-MRI: preoperative prediction of HER2 status in breast cancer","volume":"8","author":"Song","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2025.107019_bib10","article-title":"Synthetic MRI in breast cancer: differentiating benign from malignant lesions and predicting immunohistochemical expression status","volume":"13","author":"Li","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.crad.2025.107019_bib11","article-title":"High-spatial-resolution multishot multiplexed sensitivity-encoding diffusion-weighted imaging for improved quality of breast images and differentiation of breast lesions: a feasibility study","volume":"2","author":"Naranjo","year":"2020","journal-title":"Radiol Imaging Cancer"},{"key":"10.1016\/j.crad.2025.107019_bib12","article-title":"Comparison of MUSE-DWI and conventional DWI in the application of invasive breast cancer and malignancy grade prediction: a comparative study","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.crad.2025.107019_bib13","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1007\/s00330-013-2937-4","article-title":"BOLD-MRI of breast invasive ductal carcinoma: correlation of R2\u2217 value and the expression of HIF-1\u03b1","volume":"23","author":"Liu","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2025.107019_bib14","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00262-019-02407-8","article-title":"The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer","volume":"68","author":"Sofopoulos","year":"2019","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.crad.2025.107019_bib15","article-title":"High peritumoral and intratumoral T2 signal intensity in HER2-positive breast cancers on preneoadjuvant breast MRI: assessment of associations with histopathologic characteristics","volume":"222","author":"Jirarat","year":"2024","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.crad.2025.107019_bib16","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1007\/s00330-022-08539-3","article-title":"Intratumoral and peritumoral radiomics based on dynamic contrast-enhanced MRI for preoperative prediction of intraductal component in invasive breast cancer","volume":"32","author":"Xu","year":"2022","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2025.107019_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D slicer as an image computing platform for the quantitative imaging network","volume":"30","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.crad.2025.107019_bib18","series-title":"Breast imaging reporting and data system (BI-RADS), Breast imaging atlas","author":"D\u2019Orsi","year":"2018"},{"key":"10.1016\/j.crad.2025.107019_bib19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/jmri.26697","article-title":"Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer","volume":"50","author":"Horvat","year":"2019","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.crad.2025.107019_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12957-018-1538-8","article-title":"Role of perfusion parameters on DCE-MRI and ADC values on DWMRI for invasive ductal carcinoma at 3.0 Tesla","volume":"16","author":"Liu","year":"2018","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.crad.2025.107019_bib21","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/jmri.24934","article-title":"Histogram analysis of apparent diffusion coefficient at 3.0T: correlation with prognostic factors and subtypes of invasive ductal carcinoma","volume":"42","author":"Kim","year":"2015","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.crad.2025.107019_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/jmri.27362","article-title":"Enhanced masses on contrast-enhanced breast: differentiation using a combination of dynamic contrast-enhanced MRI and quantitative evaluation with synthetic MRI","volume":"53","author":"Matsudo","year":"2021","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.crad.2025.107019_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1148\/radiol.2018180836","article-title":"Three-dimensional MR fingerprinting for quantitative breast imaging","volume":"290","author":"Chen","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2025.107019_bib24","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2463\/mrms.mp.2019-0201","article-title":"Peritumoral fat content correlates with histological prognostic factors in breast carcinoma: a study using iterative decomposition of water and fat with echo asymmetry and least-squares estimation (IDEAL)","volume":"20","author":"Hisanaga","year":"2021","journal-title":"Magn Reson Med Sci"},{"key":"10.1016\/j.crad.2025.107019_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.mri.2018.02.004","article-title":"Study of lipid metabolism by estimating the fat fraction in different breast tissues and in various breast tumor sub-types by in vivo 1H MR spectroscopy","volume":"49","author":"Agarwal","year":"2018","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.crad.2025.107019_bib26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.2561","article-title":"Association of peritumoral radiomics with tumor biology and pathologic response to preoperative targeted therapy for HER2 (ERBB2)-Positive breast cancer","volume":"2","author":"Braman","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.crad.2025.107019_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41698-021-00163-6","article-title":"Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer","volume":"5","author":"Grigulo","year":"2021","journal-title":"NPJ Precis Oncol"},{"key":"10.1016\/j.crad.2025.107019_bib28","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.3390\/cancers13184635","article-title":"The impact of tumor edema on T2-weighted 3T-MRI invasive breast cancer histological characterization: a pilot radiomics study","volume":"13","author":"Santucci","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.crad.2025.107019_bib29","article-title":"Radiomics analysis of intratumoral and different peritumoral regions from multiparametric MRI for evaluating HER2 status of breast cancer: a comparative study","volume":"10","author":"Zhou","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.crad.2025.107019_bib30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5152\/dir.2022.20664","article-title":"Digital breast tomosynthesis-based peritumoral radiomics approaches in the differentiation of benign and malignant breast lesions","volume":"28","author":"Niu","year":"2022","journal-title":"Diagn Interv Radiol"},{"key":"10.1016\/j.crad.2025.107019_bib31","article-title":"Use of MRI radiomics models in evaluating the low HER2 expression in breast cancer","volume":"20","author":"Li","year":"2024","journal-title":"Curr Med Imaging"},{"key":"10.1016\/j.crad.2025.107019_bib32","article-title":"Multiparametric MRI-based radiomic nomogram for predicting HER-2 2+ status of breast cancer","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926025002247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926025002247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T21:07:20Z","timestamp":1767820040000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926025002247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":32,"alternative-id":["S0009926025002247"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2025.107019","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combining intratumoral and peritumoral multimodality magnetic resonance imaging (MRI) to predict the expression level of human epidermal growth factor receptor-2 (HER-2) in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2025.107019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"107019"}}